Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Twelve-Month Chronic Efficacy and Safety of Diepalrestat in Adult Subjects With Diabetic Peripheral Neuropathy (DPN), A Randomized, Double-Blind, Placebo-Controlled Study

NCT02332005 is registered in ClinicalTrials.gov with NeuromaxBionevia as lead sponsor.

NCT NCT02332005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02332005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Twelve-Month Chronic Efficacy and Safety of Diepalrestat in Adult Subjects With Diabetic Peripheral Neuropathy (DPN), A Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
NeuromaxBionevia
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2014
Completion date
November 30, 2017
Enrollment
330 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathy